What is Snap-8?
Snap-8 (acetyl octapeptide-3) is a cosmetic peptide marketed in skincare as a gentle alternative to botulinum toxin. It is an extension of the well-known argireline peptide and is meant to soften expression lines (forehead, eyes).
Important: Snap-8 is a topical peptide for the skin, not an injectable or oral agent. We carry it as a 10mg vial with freeze-dried powder for use on the skin, for example dissolved in a serum or cream. Do not inject.
Comparison
Two routes to SNAP-25 and a different one
Snap-8 mimics SNAP-25 and is applied to the skin, botulinum toxin A cleaves SNAP-25 and is injected. GHK-Cu works in a completely different way.
How it works
Snap-8 mimics a part of the protein SNAP-25 and competes with it for a place in the so-called SNARE complex. When this complex is slightly disrupted, the nerve endings release less messenger, gently dampening the muscle tension of expression lines. That is the same basic principle as botulinum toxin, just much milder and topical. The principle is documented for related SNAP-25 peptides (Gutierrez, 1997; argireline: Blanes-Mira, 2002).
Where it acts
Where Snap-8 is meant to act
Tap a point or a card. The principle was shown with the related hexapeptide.
Known targets2
Compound PubChem CID 71587832 (Snap-8): one described target, Is mimicked, the peptide disturbs formation of the SNARE complex. Shown with the related hexapeptide, not with Snap-8.
- Gene
- SNAP25
- UniProt
- P60880
- ChEMBL
- CHEMBL2364159
- Action
- Is mimicked, the peptide disturbs formation of the SNARE complex. Shown with the related hexapeptide, not with Snap-8
Use
Dosing
Dosing
Dosing, titration and syringe
Loading the dosing information …
- Getting started and stepping up, drawn as a staircase
- Units on the U-100 syringe for every step
- How long one vial lasts
What the research shows
Snap-8 is described in cosmetic research as a topical anti-wrinkle peptide, with manufacturer data on reduced wrinkle depth. According to the manufacturer it is considered somewhat more effective than its predecessor argireline. Published data mainly concern the related argireline (Blanes-Mira, 2002) and a study with microneedle patches in which Snap-8 was one of several ingredients (Avcil, 2020). There is no independent clinical study on Snap-8 alone, which should be noted honestly.
Study results
What the trials measured
Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.
Wrinkles around the eyes after 4 weeks3
Share with visible improvement in the assessment, 60 participants, applied twice daily
Values according to the abstract. Measured skin roughness also fell only in the hexapeptide group. Measured with the related hexapeptide, not with Snap-8.
Skin after 12 weeks of microneedle patches4
Change in percent, patches with several active ingredients including Snap-8, no comparison group
Values according to the abstract. Besides Snap-8 the patches contained other peptides, adenosine and seaweed extracts. Which share is due to Snap-8 cannot be read from this. No skin reactions occurred.
Research status
Where the research stands
Snap-8 is not listed on ClinicalTrials.gov and has no publication of its own. The data come from cosmetic research and from the related hexapeptide. As of 26 Oct 2026. 5
Side effects
- Topically generally well tolerated, occasionally mild skin irritation.
- Patch-test a small area if your skin is sensitive.
Storage
Store cool, dry and protected from light, out of reach of children. Keep the original container closed and mind the expiry date.